Earnings Feed
Start Free
PROGENICS PHARMACEUTICALS INC·4

Sep 11, 7:23 PM ET

DALTON MARK F 4

4 · PROGENICS PHARMACEUTICALS INC · Filed Sep 11, 2003

Insider Transaction Report

Form 4
Period: 2003-04-01
PROGENICS PHARMACEUTICALS INCPGNX
DALTON MARK F
Director
Transactions
  • Award

    Stock Option (Right to Buy)

    2003-04-01+2,500→ 2,500 total
    Exercise: $4.41From: 2003-04-01Exp: 2013-03-31→ Common Stock (2,500 underlying)
  • Award

    Stock Option (Right to Buy)

    2003-07-01+10,000→ 10,000 total
    Exercise: $15.06From: 2003-07-01Exp: 2013-06-30→ Common Stock (10,000 underlying)
Holdings

  • Common Stock, par value $0.0013 per share ("Common Stock")

    68,000

  • Common Stock, par value $0.0013 per share ("Common Stock")

    (indirect: By DF Partners)
    16,500

  • Common Stock, par value $0.0013 per share ("Common Stock")

    (indirect: By Tudor Group)
    2,342,388
Footnotes (3)
  • [F1]The Reporting Person disclaims beneficial ownership of the securities reported herein as indirectly owned except to the extent of his pecuniary interest in such securities, and this report shall not be deemed an admission that the Reporting Person is the beneficial owner of such securities, except to the extent of his pecuniary interest in such securities, for purposes of Section 16 or for any other purpose.
  • [F2]See Remarks.
  • [F3]The Reporting Person is the General Partner of DF Partners.

Documents

2 files